![](/img/cover-not-exists.png)
Initial experience with bosentan (Tracleer®) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children
N. Gilbert, Y.-C. Luther, O. Miera, N. Nagdyman, P. Ewert, F. Berger, P. E. Lange, I. Schulze-NeickVolume:
94
Pages:
5
DOI:
10.1007/s00392-005-0266-6
Date:
September, 2005
File:
PDF, 205 KB
2005